Valore202020212022202320242025TTMSpese di vendita, generali e amministrative5.36 B6.43 B6.46 B7.13 B7.68 B8.65 B8.65 BRicerca e sviluppo984 M1.24 B1.45 B1.39 B1.47 B1.62 B1.62 BReddito operativo2.22 B2.58 B2.84 B3.89 B3.69 B4.89 B4.89 BProventi non operativi, Totale-269 M-303 M-158 M-215 M-197 M232 M232 MOneri finanziari, al netto degli interessi capitalizzati315 M337 M337 M356 M396 M607 M582 MProventi non operativi, esclusi gli oneri finanziari-584 M-640 M-495 M-571 M-593 M-375 M-350 MEntrate/uscite straordinarie———————Utile al lordo delle imposte1.95 B2.28 B2.68 B3.67 B3.49 B4.51 B4.51 BQuota di utile———————Imposte355 M287 M325 M508 M499 M1.27 B1.27 BInteressi di minoranza———————Altri proventi/oneri al netto delle imposte———————Utile netto al lordo delle attività cessate1.6 B1.99 B2.36 B3.17 B2.99 B3.25 B3.25 BAttività cessate———————Utile netto1.6 B1.99 B2.36 B3.17 B2.99 B3.25 B3.25 BRegolazione della diluizione———————Dividendi privilegiati———————Utile netto diluito attribuibile agli azionisti ordinari1.6 B1.99 B2.36 B3.17 B2.99 B3.25 B3.25 BUtile base per azione (EPS base)4.265.296.238.347.868.498.49Utile diluito per azione (EPS diluito)4.25.216.178.257.768.48.4Numero medio di azioni ordinarie in circolazione375.5 M377 M378.2 M379.6 M381 M382.2 M1.53 BAzioni diluite in circolazione380.3 M382.3 M382.2 M383.7 M385.6 M386.5 M1.55 BEBITDA3.3 B3.86 B4.12 B5.23 B5.12 B6.46 B6.46 BEBIT2.22 B2.58 B2.84 B3.89 B3.69 B4.89 B4.89 BCosto del fatturato5.29 B6.14 B6.87 B7.44 B8.15 B9.05 B9.05 BAltri costi del venduto———————Ammortamento e svalutazione (liquidità)1.08 B1.27 B1.28 B1.34 B1.43 B1.57 B1.57 B
Stryker Corporation
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000.